Orgenesis Inc. Common Stock
ORGS
ORGS was delisted on the 18th of October, 2024.
19 hedge funds and large institutions have $784K invested in Orgenesis Inc. Common Stock in 2023 Q4 according to their latest regulatory filings, with 2 funds opening new positions, 6 increasing their positions, 4 reducing their positions, and 3 closing their positions.
50% more repeat investments, than reductions
Existing positions increased: 6 | Existing positions reduced: 4
5% less funds holding
Funds holding: 20 → 19 (-1)
20% less capital invested
Capital invested by funds: $980K → $784K (-$196K)
33% less first-time investments, than exits
New positions opened: 2 | Existing positions closed: 3
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Jane Street
New York
|
+$7.69K |
| 2 |
XT
XTX Topco
George Town,
Cayman Islands
|
+$7.54K |
| 3 |
BlackRock
New York
|
+$6.4K |
| 4 |
UBS Group
Zurich,
Switzerland
|
+$660 |
| 5 |
TFGT
TS Financial Group (TSFG)
Lake Forest,
Illinois
|
+$58 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Walleye Capital
New York
|
-$17K |
| 2 |
Prudential Financial
Newark,
New Jersey
|
-$5.13K |
| 3 |
Barclays
London,
United Kingdom
|
-$4.27K |
| 4 |
Morgan Stanley
New York
|
-$4K |
| 5 |
Renaissance Technologies
New York
|
-$3.08K |
ORGS Hedge Fund Activity: Q4 2023 in Review
19 of the 6,860 institutional investors tracked by Wall St. Rank reported a position in Orgenesis Inc. Common Stock (ORGS) for Q4 2023, worth a combined $784K — down 20% from $980K a quarter earlier.
Sellers outnumbered buyers: 3 funds closed out of ORGS and 2 opened new positions — a net loss of 1 holder — while 4 trimmed existing stakes and 6 added.
The largest buyer was Jane Street, opening a new position worth an estimated $7.69K. The largest seller was Walleye Capital, exiting entirely with an estimated $17K sold.
- 19 institutional investors held Orgenesis Inc. Common Stock (ORGS) as of Q4 2023, down from 20 in Q3 2023.
- Funds reported $784K of Orgenesis Inc. Common Stock stock for Q4 2023, down 20% quarter-over-quarter.
- 2 funds opened new Orgenesis Inc. Common Stock positions in Q4 2023 and 3 closed out, a net change of -1 holder.
- The largest Orgenesis Inc. Common Stock buyer in Q4 2023 was Jane Street, an estimated $7.69K added.
- The largest Orgenesis Inc. Common Stock seller in Q4 2023 was Walleye Capital, an estimated $17K sold.
Based on aggregated 13F filings for Q4 2023.